共 50 条
- [3] Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2016, 6
- [7] Correlation between changes in urticaria symptoms and sleep experience in patients with chronic spontaneous/idiopathic urticaria (CSU/CIU): A post-hoc analysis from 2 randomized, double-blind, placebo-controlled phase 3 trials of omalizumab [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB43 - AB43
- [10] Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (02): : 196 - 204